Search by company

Visit the ACHEMA 2009 web site

Galapagos

Generaal de Wittelaan L11 A3
Mechelen
2800
Belgium

Latest articles from this company

News releases from this company

Morphosys and Galapagos to codevelop antibodies

Morphosys and Galapagos have entered into an alliance to codevelop novel therapeutic antibodies in bone and joint disease.

News from Laboratorytalk, 1 December 2008

Merck Serono to use Softfocus compounds

Galapagos has announced collaboration agreements with Merck Serono.

News from Laboratorytalk, 24 November 2008

BioFocus DPI adds to its drug discovery services

BioFocus DPI, Galapagos NV's service division, has added structural biology to its pre-clinical drug discovery services following the acquisition of Sareum Holdings by Galapagos.

News from Laboratorytalk, 29 August 2008

Galapagos expands relationship with AstraZeneca

Galapagos has announced that its service division, BioFocus DPI, has entered into a new drug discovery collaboration with the pharmaceutical manufacturer AstraZeneca

News from Laboratorytalk, 10 August 2007

Target discover deal produces results

Boehringer Ingelheim has successfully used the SilenceSelect gene knock-down platform to identify a number of genes that were shown to influence viral replication in human cells

News from Laboratorytalk, 9 February 2005

Target discovery alliance in asthma

GlaxoSmithKline and Galapagos enter agreement for target identification in respiratory and inflammatory diseases

News from Laboratorytalk, 8 February 2005

Not what you're looking for? Search the site.

Back to topBack to top

Featured articles

Contact
Pro-talk

Reach an audience of thousands

Visit the Fischer Instrumentation (GB) web site
A Pro-talk Publication

A Pro-talk publication